Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2023 Publisher: Glaxo Wellcome UK Limited trading as GlaxoSmithKline UK., GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK
Zyban 150 mg prolonged release tablets.
| Pharmaceutical Form |
|---|
|
Prolonged release tablet. White, film-coated, biconvex, round tablet printed on one side with GX CH7 and plain on the other side. |
Each tablet contains bupropion hydrochloride 150 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Bupropion |
Bupropion is a selective inhibitor of the neuronal re-uptake of catecholamines (noradrenaline and dopamine) with minimal effect on the re-uptake of indolamines (serotonin) and does not inhibit either monoamine oxidase. The mechanism by which bupropion enhances the ability of patients to abstain from smoking is unknown. However, it is presumed that this action is mediated by noradrenergic and/or dopaminergic mechanisms. |
| List of Excipients |
|---|
|
Tablet core: Microcrystalline cellulose Film coat: Hypromellose Printing ink: Iron oxide black (E172) |
Cartons containing cold form foil/foil child-resistant blister packs (PA-Alu-PVC/Paper-Alu).
30, 40, 50, 60 or 100 tablets are supplied in each pack. Each blister strip contains 10 tablets. Not all pack sizes may be marketed.
Glaxo Wellcome UK Limited trading as GlaxoSmithKline UK., GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK
PL 10949/0340
7 June 2000/1 Dec 2004
| Drug | Countries | |
|---|---|---|
| ZYBAN | Australia, Brazil, Canada, France, Ireland, Israel, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
